Recent advances in drug delivery of celastrol for enhancing efficiency and reducing the toxicity
Open Access
- 16 February 2024
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 15, 1137289
Abstract
Celastrol is a quinone methyl triterpenoid monomeric ingredient extracted from the root of Tripterygium wilfordii. Celastrol shows potential pharmacological activities in various diseases, which include inflammatory, obesity, cancer, and bacterial diseases. However, the application prospect of celastrol is largely limited by its low bioavailability, poor water solubility, and undesired off-target cytotoxicity. To address these problems, a number of drug delivery methods and technologies have been reported to enhance the efficiency and reduce the toxicity of celastrol. We classified the current drug delivery technologies into two parts. The direct chemical modification includes nucleic acid aptamer–celastrol conjugate, nucleic acid aptamer–dendrimer–celastrol conjugate, and glucolipid–celastrol conjugate. The indirect modification includes dendrimers, polymers, albumins, and vesicular carriers. The current technologies can covalently bond or encapsulate celastrol, which improves its selectivity. Here, we present a review that focalizes the recent advances of drug delivery strategies in enhancing the efficiency and reducing the toxicity of celastrol.Keywords
This publication has 64 references indexed in Scilit:
- Formulation, characterization, and evaluation of in vitro skin permeation and in vivo pharmacodynamics of surface-charged tripterine-loaded nanostructured lipid carriersInternational Journal of Nanomedicine, 2012
- Quantitative Proteomics Reveals Cellular Targets of CelastrolPLOS ONE, 2011
- Formulation and Evaluation of Celastrol-Loaded LiposomesMolecules, 2011
- Celastrol Inhibits Breast Cancer Cell Invasion via Suppression of NF-ĸB-mediated Matrix Metalloproteinase-9 ExpressionCellular Physiology and Biochemistry, 2011
- Aptamers as therapeuticsNature Reviews Drug Discovery, 2010
- Celastrol suppresses allergen-induced airway inflammation in a mouse allergic asthma modelEuropean Journal of Pharmacology, 2009
- Therapeutic and diagnostic applications of dendrimers for cancer treatment☆Advanced Drug Delivery Reviews, 2008
- Molecular Understanding and Modern Application of Traditional Medicines: Triumphs and TrialsCell, 2007
- Exosomal-like vesicles are present in human blood plasmaInternational Immunology, 2005
- Celastrol inhibits pro-inflammatory cytokine secretion in Crohn’s disease biopsiesBiochemical and Biophysical Research Communications, 2004